Data from EMC - Curated by Toby Galbraith - Last updated 19 April 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).

IDELVION can be used for all age groups.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients

Visit Oral Anticoagulation Reversal

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation

More information

Category Value
Agency product number EMEA/H/C/003955
Orphan designation Yes
Date First Approved 11-05-2016
Type POM
Marketing authorisation holder CSL Behring GmbH

Related Content